ENHERTU® (Trastuzumab Deruxtecan, T-DXd) Outperforms Chemotherapy in Metastatic Breast Cancer: SABCS 2024 DESTINY-Breast06 Results Breast 2 Mins Read6 The San Antonio Breast Cancer Symposium (SABCS) 2024 showcased new data from the DESTINY-Breast06 study, examining the efficacy of ENHERTU®…
EMBER-3 Reveal: Imlunestrant – Standalone Star or Team Player with Abemaciclib? Breast 2 Mins Read20 EMBER-3 Trial: Pioneering Results in Advanced Breast Cancer Treatment The results of the Phase 3 EMBER-3 trial were unveiled at…
